The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program

Overview of attention for article published in Trials, January 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 15,253 followers.

RT @UMCPC_official: 1. Only 44% of Australians currently take part in bowel cancer screening - Our #SMARTscreen trial used text message pro…

RT @UMCPC_official: 1. Only 44% of Australians currently take part in bowel cancer screening - Our #SMARTscreen trial used text message pro…

RT @UMCPC_official: 1. Only 44% of Australians currently take part in bowel cancer screening - Our #SMARTscreen trial used text message pro…

RT @UMCPC_official: 1. Only 44% of Australians currently take part in bowel cancer screening - Our #SMARTscreen trial used text message pro…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.